Citation 1: Rosenberg HF, Ackerman SJ, Tenen DG, et al. Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med. 1989;170(1):163-76. Published 1989 Jul 1. doi:10.1084/jem.170.1.163
Citation 2: Hamann KJ, Ten RM, Loegering DA, et al. Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. Genomics. 1990;7(4):535-46. Published 1990 Aug. doi:10.1016/0888-7543(90)90197-3
Citation 3: Barker RL, Loegering DA, Ten RM, et al. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. J Immunol. 1989;143(3):952-5. Published 1989 Aug 1. doi:
Citation 4: Zhang J, Rosenberg HF, Rosenberg HF. Sequence variation at two eosinophil-associated ribonuclease loci in humans. Genetics. 2000;156(4):1949-58. Published 2000 Dec. doi:10.1093/genetics/156.4.1949
Citation 5: Heilig R, Eckenberg R, Petit JL, et al. The DNA sequence and analysis of human chromosome 14. Nature. 2003;421(6923):601-7. Published 2003 Feb 6. doi:10.1038/nature01348
Citation 6: Gerhard DS, Wagner L, Feingold EA, et al. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004;14(10B):2121-7. Published 2004 Oct. doi:10.1101/gr.2596504
Citation 7: Gleich GJ, Loegering DA, Bell MP, et al. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A. 1986;83(10):3146-50. Published 1986 May. doi:10.1073/pnas.83.10.3146
Citation 8: Gabay JE, Scott RW, Campanelli D, et al. Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A. 1989;86(14):5610-4. Published 1989 Jul. doi:10.1073/pnas.86.14.5610
Citation 9: Ulrich M, Petre A, Youhnovski N, et al. Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase. J Biol Chem. 2008;283(42):28629-40. Published 2008 Oct 17. doi:10.1074/jbc.M801196200
Citation 10: Torrent M, de la Torre BG, Nogués VM, et al. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem J. 2009;421(3):425-34. Published 2009 Jul 15. doi:10.1042/BJ20082330
Citation 11: Torrent M, Odorizzi F, Nogués MV, et al. Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region. Biomacromolecules. 2010;11(8):1983-90. Published 2010 Aug 9. doi:10.1021/bm100334u
Citation 12: Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, et al. N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015;15(14):2519-24. Published 2015 Jul. doi:10.1002/pmic.201400617
Citation 13: Boix E, Leonidas DD, Nikolovski Z, et al. Crystal structure of eosinophil cationic protein at 2.4 A resolution. Biochemistry. 1999;38(51):16794-801. Published 1999 Dec 21. doi:10.1021/bi9919145
Citation 14: MallorquÃ-Fernández G, Pous J, Peracaula R, et al. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution. J Mol Biol. 2000;300(5):1297-307. Published 2000 Jul 28. doi:10.1006/jmbi.2000.3939
Citation 15: Mohan CG, Boix E, Evans HR, et al. The crystal structure of eosinophil cationic protein in complex with 2',5'-ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site. Biochemistry. 2002;41(40):12100-6. Published 2002 Oct 8. doi:10.1021/bi0264521